Jacques Fantini, Fodil Azzaz, Anaïs Aulas, Henri Chahinian, Nouara Yahi. "Correction: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53." Scientific Reports, 2025. doi:10.1038/s41598-025-07762-4